Santa Cruz, CA · Founded 2011 · Privately Held (backing)
Developer of an embolic protection catheter designed to offer embolic protection during percutaneous heart valve repair and replacement procedures. Emboline is based in Santa Cruz, CA and was founded in 2011. It was valued at $151 million at its later-stage round in Jun 2021, the last priced event on record. It has raised $102 million across 2 recorded rounds; the latest was a $55.4 million later-stage round in May 2021.
PMV mark · valuation
$151.4M
Oct 2026
Priced at
its later-stage round
Jun 2021
Total raised
$102.0M
Last round
Later Stage VC
May 2021
No prints on record
No secondary trades in Emboline shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Emboline with a free account
·The complete investor list: 12 names
·Watch Emboline: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Emboline stock.
